Literature DB >> 14526171

Understanding fragile X syndrome: insights from animal models.

C E Bakker1, B A Oostra.   

Abstract

The fragile X mental retardation syndrome is caused by large methylated expansions of a CGG repeat in the FMR1 gene leading to the loss of expression of FMRP, an RNA-binding protein. FMRP is proposed to act as a regulator of mRNA transport or translation that plays a role in synaptic maturation and function. To study the physiological function of the FMR1 protein, mouse and Drosophila models have been developed. The loss-of-function mouse model shows slightly enlarged testes, a subtle behavioral phenotype, and discrete anomalies of dendrite spines similar to those observed in brains of patients. Studies in Drosophila indicate that FXMR plays an important role in synaptogenesis and axonal arborization, which may underlie the observed deficits in flight ability and circadian behavior of FXR mutant flies. The relevance of these studies to our understanding of fragile X syndrome is discussed. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14526171     DOI: 10.1159/000072845

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  24 in total

Review 1.  Fragile X: leading the way for targeted treatments in autism.

Authors:  Lulu W Wang; Elizabeth Berry-Kravis; Randi J Hagerman
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

2.  Pharmacological reversal of synaptic plasticity deficits in the mouse model of fragile X syndrome by group II mGluR antagonist or lithium treatment.

Authors:  Catherine H Choi; Brian P Schoenfeld; Aaron J Bell; Paul Hinchey; Maria Kollaros; Michael J Gertner; Newton H Woo; Michael R Tranfaglia; Mark F Bear; R Suzanne Zukin; Thomas V McDonald; Thomas A Jongens; Sean M J McBride
Journal:  Brain Res       Date:  2010-11-12       Impact factor: 3.252

3.  iPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth.

Authors:  Matthew E Doers; Michael T Musser; Robert Nichol; Erich R Berndt; Mei Baker; Timothy M Gomez; Su-Chun Zhang; Leonard Abbeduto; Anita Bhattacharyya
Journal:  Stem Cells Dev       Date:  2014-04-30       Impact factor: 3.272

Review 4.  Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders.

Authors:  Michael R Hunsaker
Journal:  Prog Neurobiol       Date:  2012-01-13       Impact factor: 11.685

5.  Deficits in the activity of presynaptic γ-aminobutyric acid type B receptors contribute to altered neuronal excitability in fragile X syndrome.

Authors:  Ji-Yong Kang; Jayashree Chadchankar; Thuy N Vien; Michelle I Mighdoll; Thomas M Hyde; Robert J Mather; Tarek Z Deeb; Menelas N Pangalos; Nicholas J Brandon; John Dunlop; Stephen J Moss
Journal:  J Biol Chem       Date:  2017-02-17       Impact factor: 5.157

Review 6.  CGG repeat in the FMR1 gene: size matters.

Authors:  R Willemsen; J Levenga; B A Oostra
Journal:  Clin Genet       Date:  2011-06-30       Impact factor: 4.438

7.  Abnormal development of auditory responses in the inferior colliculus of a mouse model of Fragile X Syndrome.

Authors:  Anna O Nguyen; Devin K Binder; Iryna M Ethell; Khaleel A Razak
Journal:  J Neurophysiol       Date:  2020-04-22       Impact factor: 2.714

8.  Transcriptome analysis of rat dorsal hippocampal CA1 after an early life seizure induced by kainic acid.

Authors:  Heather O'Leary; Lauren Vanderlinden; Lara Southard; Anna Castano; Laura M Saba; Tim A Benke
Journal:  Epilepsy Res       Date:  2020-01-30       Impact factor: 3.045

9.  Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome.

Authors:  Giulia Curia; Thomas Papouin; Philippe Séguéla; Massimo Avoli
Journal:  Cereb Cortex       Date:  2008-09-11       Impact factor: 5.357

10.  Craniofacial characteristics of fragile X syndrome in mouse and man.

Authors:  Inge Heulens; Michael Suttie; Andrei Postnov; Nora De Clerck; Concetta S Perrotta; Teresa Mattina; Francesca Faravelli; Francesca Forzano; R Frank Kooy; Peter Hammond
Journal:  Eur J Hum Genet       Date:  2012-12-05       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.